Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThermoDox + HIFU for Painful Bone Metastases
NCT01640847Phase 2Withdrawn
- Sponsor
- Imunon, Inc.
- Start
- Jul 2012
- Primary completion
- Jun 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of ThermoDox in bone metastases, sponsored by Imunon, Inc.. Planned start Jul 2012; status: withdrawn.
02
Drugs
ThermoDox
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT01640847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640847.